HRP20080602T3 - Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds - Google Patents
Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compoundsInfo
- Publication number
- HRP20080602T3 HRP20080602T3 HR20080602T HRP20080602T HRP20080602T3 HR P20080602 T3 HRP20080602 T3 HR P20080602T3 HR 20080602 T HR20080602 T HR 20080602T HR P20080602 T HRP20080602 T HR P20080602T HR P20080602 T3 HRP20080602 T3 HR P20080602T3
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- substituted
- phenyl
- sulfonilamino
- hidroxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10348298A DE10348298A1 (de) | 2003-10-17 | 2003-10-17 | Amidomethyl-substituierte 2-(4-Sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| PCT/EP2004/052539 WO2005037780A2 (de) | 2003-10-17 | 2004-10-14 | Amidomethyl-substituierte 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20080602T3 true HRP20080602T3 (en) | 2008-12-31 |
Family
ID=34442032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080602T HRP20080602T3 (en) | 2003-10-17 | 2008-11-20 | Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1678130B1 (pl) |
| JP (1) | JP4791968B2 (pl) |
| KR (1) | KR20060129170A (pl) |
| CN (1) | CN100532375C (pl) |
| AR (1) | AR046106A1 (pl) |
| AT (1) | ATE405547T1 (pl) |
| AU (1) | AU2004281195B2 (pl) |
| BR (1) | BRPI0415523A (pl) |
| CA (1) | CA2542813C (pl) |
| DE (3) | DE10348298A1 (pl) |
| DK (1) | DK1678130T3 (pl) |
| ES (1) | ES2313126T3 (pl) |
| HK (1) | HK1096960A1 (pl) |
| HR (1) | HRP20080602T3 (pl) |
| IL (1) | IL174950A (pl) |
| MX (1) | MXPA06003958A (pl) |
| NO (1) | NO20062202L (pl) |
| PL (1) | PL1678130T3 (pl) |
| PT (1) | PT1678130E (pl) |
| RU (1) | RU2355685C2 (pl) |
| SI (1) | SI1678130T1 (pl) |
| TW (1) | TWI321564B (pl) |
| UA (1) | UA82907C2 (pl) |
| WO (1) | WO2005037780A2 (pl) |
| ZA (1) | ZA200602788B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1871758B1 (en) * | 2005-04-12 | 2010-08-25 | Abbott Products GmbH | Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers |
| US7714150B2 (en) | 2005-04-12 | 2010-05-11 | Solvay Pharmaceuticals Gmbh | Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives |
| JP4943429B2 (ja) * | 2005-07-22 | 2012-05-30 | メルク・シャープ・エンド・ドーム・コーポレイション | カリウムチャネル阻害剤 |
| GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
| GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| NO3175985T3 (pl) | 2011-07-01 | 2018-04-28 | ||
| JP2015504923A (ja) | 2012-01-27 | 2015-02-16 | ギリアード サイエンシーズ， インコーポレイテッド | 後期ナトリウムイオンチャネル遮断剤およびカリウムイオンチャネル遮断剤を使用する併用療法 |
| WO2014134419A1 (en) | 2013-03-01 | 2014-09-04 | Gilead Sciences, Inc. | Use of ikach blockers for the treatment of cardiac diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ282172B6 (cs) * | 1992-11-30 | 1997-05-14 | Smithkline Beecham Plc | Benzpyranové analogy pro léčení úzkosti, mánie, deprese nebo symptomů po přerušení podávání drog nebo léčiv, způsob přípravy těchto sloučenin, jejich použití a farmaceutický prostředek obsahující tyto sloučeniny |
| DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
| WO2000012077A1 (en) * | 1998-09-01 | 2000-03-09 | Bristol-Myers Squibb Company | Potassium channel inhibitors and method |
| WO2000058300A1 (fr) * | 1999-03-25 | 2000-10-05 | Nissan Chemical Industries, Ltd. | Derives du chroman |
| JP2000336085A (ja) * | 1999-03-25 | 2000-12-05 | Nissan Chem Ind Ltd | クロマン誘導体 |
| AU781365B2 (en) * | 1999-12-21 | 2005-05-19 | Icagen, Inc. | Potassium channel inhibitors |
-
2003
- 2003-10-17 DE DE10348298A patent/DE10348298A1/de not_active Withdrawn
-
2004
- 2004-10-13 AR ARP040103705A patent/AR046106A1/es not_active Application Discontinuation
- 2004-10-13 TW TW093130943A patent/TWI321564B/zh not_active IP Right Cessation
- 2004-10-14 CN CNB2004800283503A patent/CN100532375C/zh not_active Expired - Fee Related
- 2004-10-14 MX MXPA06003958A patent/MXPA06003958A/es active IP Right Grant
- 2004-10-14 PT PT04817204T patent/PT1678130E/pt unknown
- 2004-10-14 RU RU2006116629/04A patent/RU2355685C2/ru not_active IP Right Cessation
- 2004-10-14 DE DE112004001659T patent/DE112004001659D2/de not_active Expired - Fee Related
- 2004-10-14 DE DE502004007916T patent/DE502004007916D1/de active Active
- 2004-10-14 DK DK04817204T patent/DK1678130T3/da active
- 2004-10-14 UA UAA200605330A patent/UA82907C2/uk unknown
- 2004-10-14 WO PCT/EP2004/052539 patent/WO2005037780A2/de active IP Right Grant
- 2004-10-14 AT AT04817204T patent/ATE405547T1/de active
- 2004-10-14 SI SI200430848T patent/SI1678130T1/sl unknown
- 2004-10-14 PL PL04817204T patent/PL1678130T3/pl unknown
- 2004-10-14 EP EP04817204A patent/EP1678130B1/de active Active
- 2004-10-14 ZA ZA200602788A patent/ZA200602788B/xx unknown
- 2004-10-14 JP JP2006534762A patent/JP4791968B2/ja not_active Expired - Fee Related
- 2004-10-14 AU AU2004281195A patent/AU2004281195B2/en not_active Ceased
- 2004-10-14 CA CA2542813A patent/CA2542813C/en not_active Expired - Fee Related
- 2004-10-14 KR KR1020067006939A patent/KR20060129170A/ko not_active Application Discontinuation
- 2004-10-14 ES ES04817204T patent/ES2313126T3/es active Active
- 2004-10-14 BR BRPI0415523-8A patent/BRPI0415523A/pt not_active IP Right Cessation
-
2006
- 2006-04-11 IL IL174950A patent/IL174950A/en not_active IP Right Cessation
- 2006-05-16 NO NO20062202A patent/NO20062202L/no not_active Application Discontinuation
-
2007
- 2007-02-23 HK HK07102051.5A patent/HK1096960A1/xx not_active IP Right Cessation
-
2008
- 2008-11-20 HR HR20080602T patent/HRP20080602T3/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20080602T3 (en) | Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds | |
| UY26943A1 (es) | Derivados de piridina | |
| HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| AR068413A2 (es) | Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia | |
| HN2002000300A (es) | Nuevos derivados de piperazina | |
| CR8193A (es) | Piperazina con o sustituida de grupos feniles y su uso como inhibidores de glyt 1 | |
| ATE506354T1 (de) | Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren | |
| ATE302775T1 (de) | Carbolinderivate | |
| BR0211473A (pt) | Novos compostos | |
| EA201100877A1 (ru) | Спирогетероциклические n-оксиамиды в качестве пестицидов | |
| EA200601686A1 (ru) | Замещенные производные морфолина и тиоморфолина | |
| MEP53708A (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| HRP20040280A2 (en) | LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS | |
| DK1188747T3 (da) | Phenoxypropylaminforbindelser | |
| MX2007004179A (es) | Derivados de triazolpiridina como agentes antibacterianos. | |
| UY26721A1 (es) | Nuevos derivados de la fenilglicina | |
| HRP20050213A2 (en) | 2,4-substituted indoles and their use as 5-ht6 modulators | |
| ATE346067T1 (de) | Carbolinderivate | |
| PA8576001A1 (es) | "difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion , medicamentos que comprenden estos compuestos y su uso". | |
| RS53428B (en) | COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES | |
| DK1585493T3 (da) | Triazinderivater som UV-absorbenter | |
| ATE300543T1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
| SE0302546D0 (sv) | New compounds | |
| TR200400645T4 (tr) | İkameli Fenil Piperazin türevleri, Bunların Hazırlanması ve kullanımları | |
| DK1189900T3 (da) | Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler |